NCCI Medical Price Index at 1.8% Masks 4% WC Severity Growth

From tracking NCCI's Medical Inflation Insights reports since their quarterly launch, the April 2026 edition presents the starkest data gap we have seen between price-level indices and actual claim severity. The Workers Compensation Weighted Medical Price Index (WCWMI) printed 1.8% year-over-year through March 2026, a figure that would look benign in any loss cost filing exhibit. But days later, NCCI's 2026 State of the Line presentation at AIS confirmed that actual workers compensation medical claim severity grew 4% in 2025. The 2.2-percentage-point gap between those two measures is not noise. It represents the utilization and treatment mix changes that price-only indices structurally cannot capture, and it may be the most consequential trend selection variable in the current WC filing cycle.

What the WCWMI Measures, and What It Misses

The WCWMI is a price-only index. NCCI constructs it by reweighting Bureau of Labor Statistics price indices, both PPI and CPI components, to match the actual distribution of medical spending observed in workers compensation claims through NCCI's proprietary Medical Call data across 38 states. It measures what providers charge per unit of service. It does not measure how many services are delivered per claim, which treatment protocols are being applied, or whether claims are shifting toward higher-acuity care settings.

This design choice is deliberate. Price indices isolate the inflation component, stripping out volume and mix effects to give a clean read on what is happening to the cost of each medical service. For benchmarking purposes, the WCWMI is more precise than headline CPI medical (which tracks consumer out-of-pocket costs) or PPI healthcare (which captures all-payer provider revenue). The WCWMI uses PPI for physician and hospital components, where WC reimbursement follows fee schedules tied to Medicare or state conversion factors, and CPI for drugs and equipment, where WC reimbursement tracks consumer-facing prices more closely.

But a price-only index is structurally incapable of explaining total cost growth when utilization is changing. If an injured worker receives three MRI scans instead of one, or transitions from outpatient physical therapy to a 14-day inpatient rehabilitation stay, the additional cost shows up in severity data but not in the price index. The WCWMI tells you the price per MRI is stable; it does not tell you the claim now includes two additional scans.

The Component Picture: Q1 2026 WCWMI Breakdown

NCCI's April 2026 Medical Inflation Insights report provided component-level detail that reveals why the headline 1.8% figure is so low, and where the divergent signals are concentrating.

Service Category	WCWMI Weight	March 2026 YoY	1-Year Avg	Sept 2025 Rate
Physician care	39%	1.4%	1.4%	n/a
Hospital outpatient	28%	0.9%	2.8%	2.9%
Hospital inpatient	12%	3.7%	3.4%	2.4%
Medical equipment & supplies	8%	4.1%	1.5%	0.8%
Medicinal drugs	7%	−0.2%	0.4%	n/a
Long-term care	6%	3.1%	4.1%	n/a

Two categories dominate the headline figure. Physician care (39% weight) and hospital outpatient care (28% weight) together account for 67% of the index. Both printed sub-1.5% price growth in March, pulling the composite to 1.8% despite hospital inpatient surging to 3.7% and medical equipment hitting 4.1%. NCCI itself flagged the equipment acceleration as potentially "one of the first signs of tariff-related impacts on prices in these categories," a signal that the tariff-driven equipment cost analysis we published in May explored in detail.

The drug price decline of 0.2% reflects federal pricing initiatives, including Inflation Reduction Act provisions and state formulary tightening. But this reprieve may prove temporary as new specialty drugs and GLP-1 therapies enter workers compensation formularies. Oral semaglutide's FDA approval in late 2025 opened a compensability channel that will add pharmacy cost exposure for obesity-comorbid WC claims, an effect that the WCWMI drug component will capture only through the price dimension while the utilization impact flows through severity.

The Utilization Gap: 2.2 Percentage Points of Hidden Cost Growth

The standard formulation for total medical severity trend decomposes into three multiplicative components:

Total medical severity trend = price trend × utilization trend × mix trend

The WCWMI provides the price component: 1.8% as of March 2026. NCCI's 2026 State of the Line provides the all-in severity figure: 4.0% for medical claims in 2025. The residual, approximately 2.2 percentage points, represents the combined effect of utilization changes (more services per claim) and mix shifts (claims gravitating toward costlier treatment settings and protocols).

Several drivers explain the residual. An aging workforce with higher comorbidity rates generates more imaging, longer inpatient stays, and more complex surgical interventions per claim. NCCI AIS 2026 sessions documented that workers aged 50 and older produce medical costs substantially above the total average, with Travelers data showing comorbidity multipliers of 2x to 5x on medical severity for claims involving diabetes, hypertension, or obesity. Construction and healthcare, two high-frequency WC industry classes, are also the sectors with the oldest average workforce age profiles.

Additionally, NCCI's data on fast-emerging large claims shows that 59% of claims reaching $1 million now do so within 24 months, up from 27% two decades ago. This compression reflects higher-acuity initial treatment protocols, earlier surgical intervention, and more aggressive rehabilitation programs. Each of these drivers increases the volume and intensity of services per claim without necessarily changing the price per service.

Decomposing Medical Trend for Loss Cost Filings

A pricing actuary preparing a workers compensation loss cost filing faces three options for the medical severity trend assumption. Each produces a materially different filed rate level.

Option 1: Price index only. Selecting 1.8% (or the one-year WCWMI average of 2.2%) as the medical trend assumes utilization and mix are stable or offsetting. This approach produces the lowest filed loss costs and the most favorable rate indication. It is also the approach most likely to produce inadequate rates if the utilization shift is persistent rather than transitory. From tracking rate adequacy outcomes across filing cycles, trend assumptions anchored to price-only indices have historically understated actual severity emergence in periods of rising utilization.

Option 2: Raw all-in severity. Selecting 4.0% captures the full price-plus-utilization effect but may overstate the prospective trend if the 2025 utilization spike was partly driven by one-time factors: post-pandemic deferred care, catch-up surgical volumes, or a temporary shift in claim mix toward higher-severity industry classes. Single-year severity figures are volatile, and selecting the most recent observation without smoothing introduces noise into the trend assumption.

Option 3: Decomposed price-utilization-mix framework. This is the approach that produces the most defensible trend selection. Anchor on the WCWMI for the price component, then add a separate utilization trend selected from multi-year severity-minus-price residuals, applying exponential smoothing or least-squares regression to the residual series to dampen single-year volatility.

A Worked Example: From Components to Selected Trend

Consider a pricing actuary building a 2027-effective loss cost filing in a mid-size NCCI state. The available data includes five years of WCWMI readings and corresponding NCCI medical severity observations.

Year	WCWMI (Price)	All-in Medical Severity	Residual (Utilization + Mix)
2021	1.5%	1.0%	−0.5%
2022	2.8%	5.0%	+2.2%
2023	2.6%	2.0%	−0.6%
2024	2.6%	6.0%	+3.4%
2025	1.8%	4.0%	+2.2%

The raw residual series is volatile, ranging from −0.6% to +3.4%. A three-year exponential weighted average (giving 50% weight to the most recent year, 30% to the prior year, and 20% to two years prior) produces a smoothed utilization trend of approximately 2.0%:

Smoothed utilization = (0.50 × 2.2%) + (0.30 × 3.4%) + (0.20 × −0.6%) = 1.10% + 1.02% + −0.12% = 2.0%

The selected medical severity trend then becomes:

Selected trend = price trend + smoothed utilization trend = 1.8% + 2.0% = 3.8%

Compare the three approaches side by side. The price-only selection of 1.8% yields a medical trend that is less than half the decomposed figure. On a state WC book with $500 million in medical loss costs, the difference between a 1.8% and 3.8% prospective trend, compounded over a two-year projection period, produces approximately $20 million in additional loss cost. That gap flows directly into rate adequacy: the carrier using the price-only trend is collecting $20 million less than the carrier using the decomposed framework for the same exposure base.

Component-Level Sensitivity Testing

The decomposition also enables component-level stress testing that a single composite trend cannot support. With tariff impacts driving divergent price trajectories across the six WCWMI service categories, pricing actuaries should test the sensitivity of their selected trend to plausible component-level scenarios.

Equipment price acceleration scenario. If medical equipment prices continue at 4.1% (the March 2026 pace) rather than reverting to the 1.5% one-year average, the equipment component adds 0.2 percentage points to the composite price trend. Small in isolation, but combined with a utilization trend that may itself be accelerating for equipment-intensive claims (orthopedic implants, durable medical equipment for aging workers), the compounded effect matters.

Drug price reversal scenario. If federal pricing initiatives lose effectiveness or GLP-1 therapies expand WC formulary costs, drug prices could swing from −0.2% to +3% within two filing cycles. On a 7% index weight, that reversal adds 0.2 points to the composite. The pharmacy sub-component is also the category most exposed to the physician dispensing markup distortion that WCRI documented, where 16,000% markups on dispensed topicals inflate pharmacy severity in permissive states.

Hospital outpatient reversion scenario. NCCI's own guidance suggests the 0.9% March print for hospital outpatient care (28% weight) is below the longer-term annualized trend of 3.5%. If outpatient prices revert to 3.5% as NCCI expects, the composite WCWMI rises from 1.8% toward 2.5%. Combined with the utilization trend, the selected medical severity trend under this scenario reaches 4.5%, exceeding the 2025 observed severity. This is the scenario NCCI appears to be signaling when it says the moderate Q1 pace "is unlikely to be sustained."

The CPI medical rate of 4.0% outpaced the WCWMI by 2.2 points in March 2026, and PPI healthcare services ran 2.4%. This payer-type divergence challenges actuaries who benchmark WC medical trend against broader healthcare inflation indices. The WCWMI's WC-specific weighting is the right benchmark for the price component, but actuaries should still cross-reference CPI and PPI medical for reasonableness checks, particularly when the spread between consumer-paid and provider-received medical costs widens as it did in Q1 2026.

Why This Matters

Workers compensation remains profitable. The calendar year 2025 combined ratio of 91 extended the line's streak of sub-100 performance to 12 consecutive years. But the accident year combined ratio hit 102, and reserve redundancy declined from $16 billion to $14 billion. The margin between profitability and deficit is narrower than the headline suggests, and the medical severity trend assumption is the variable with the widest plausible range.

A pricing actuary who selects 1.8% for medical trend because the WCWMI says 1.8% is making a defensible but incomplete choice. The index is measuring the right thing: WC-specific medical prices. It is simply not measuring enough. The utilization and mix components that account for the other 2.2 percentage points of actual severity growth are real, they are persistent across the 2022 through 2025 observation window, and they are being driven by structural forces (workforce aging, treatment protocol intensification, large claim acceleration) rather than transitory shocks.

The decomposed framework of anchoring to the WCWMI for price, adding a smoothed utilization residual, and stress-testing the components individually produces a selected trend of 3.8% in our worked example. That figure is closer to the 4% observed severity than to the 1.8% price index, and it gives the filing actuary a documented, replicable basis for selecting a trend that accounts for what the price index structurally excludes. With NCCI signaling that even the price index will revert toward 2.5% later in 2026, the combined medical trend for 2027-effective filings may well exceed 4%.